{
    "organizations": [],
    "uuid": "157eb4f050438673eaeb686a6ad405569898f56e",
    "author": "",
    "url": "https://www.reuters.com/article/brief-ra-pharmaceuticals-reports-q4-loss/brief-ra-pharmaceuticals-reports-q4-loss-per-share-0-67-idUSASC09SAA",
    "ord_in_thread": 0,
    "title": "BRIEF-Ra Pharmaceuticals Reports Q4 Loss Per Share $0.67",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " Ra Pharmaceuticals Reports Q4 Loss Per Share $0.67   Ra Pharmaceuticals Inc: * RA PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE * Q4 LOSS PER SHARE $0.67 * Q4 EARNINGS PER SHARE VIEW $-0.66 â€” THOMSON REUTERS I/B/E/S * RA PHARMACEUTICALS - EXPECTS CASH AND CASH EQUIVALENTS AT DEC 31, 2017 AND NET PROCEEDS OF OFFERING TO BE SUFFICIENT TO FUND OPERATIONS THROUGH 2019  ",
    "published": "2018-03-14T22:23:00.000+02:00",
    "crawled": "2018-03-14T22:39:05.002+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "ra",
        "pharmaceutical",
        "report",
        "q4",
        "loss",
        "per",
        "share",
        "ra",
        "pharmaceutical",
        "inc",
        "ra",
        "pharmaceutical",
        "report",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "result",
        "provides",
        "corporate",
        "update",
        "q4",
        "loss",
        "per",
        "share",
        "q4",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "ra",
        "pharmaceutical",
        "expects",
        "cash",
        "cash",
        "equivalent",
        "dec",
        "net",
        "proceeds",
        "offering",
        "sufficient",
        "fund",
        "operation"
    ]
}